Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin’s lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models.
Lees meer..

A butterfly’s proboscis looks like a straw — long, slender, and used for sipping — but it works more like a paper towel, according to Konstantin Kornev of Clemson University. He hopes to borrow the tricks of this piece of insect anatomy to make small probes that can sample the fluid inside of cells. Kornev presented his work at the 62nd Annual Meeting of the American Physical Society’s (APS) Division of Fluid Dynamics November 22-24 at the Minneapolis Convention Center.
Lees meer..

On the skin’s surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the skin surface trigger a pathway that prevents excessive inflammation after injury. “These germs are actually good for us,” said Richard L.
Lees meer..

Biomethylation of arsenic compounds appears to cause oxidative DNA damage and to increase their carcinogenicity, according to a new study published online November 23 in the Journal of the National Cancer Institute. Although biomethylation was once believed to detoxify inorganic arsenic, it is now thought to enhance its toxicity and potentially its carcinogenicity. To assess the role of arsenic biomethylation in oxidative DNA damage in mice, Michael P.
Lees meer..

The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells’ maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells.
Lees meer..

Answers From Iowa Kaiser Health News If this were a presidential election year, a recent report by the Iowa Committee for Value in Healthcare would be reaping a lot of attention.
Lees meer..

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for velaglucerase alfa, the company’s enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease. This is the third marketing application for velaglucerase alfa that has been submitted, with previous submissions in the United States and Canada.
Lees meer..

Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study. Diabetes is a disorder characteristic of high blood glucose and poor metabolism.
Lees meer..

AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the “Company”), a global biopharmaceutical company focused on endocrine therapy and oncology, announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.
Lees meer..

Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market.
Lees meer..